Central to this rebellious movement were the iconic logos and graphics that came to represent the various punk bands and their anti-establishment ideologies. More than just visual identifiers, these ...

GSK (GSK) said it is “pleased” that the Advisory Committee on Immunization Practices voted in favor of recommending the use of RSV vaccines including GSK’s AREXVY in adults aged 50-59 who ...

In spring 2021, my family sold a big lump of GSK shares. Four years later, we have no regrets. Indeed, with the GSK share price stumbling, we may buy soon. When investing, your capital is at risk.

A recent breakthrough in transparent solar panels could seamlessly integrate clean energy into building design by transforming ordinary windows into power generators. “We are the first to achieve this ...

The sale of counterfeit branded goods is strictly prohibited on Shopee. But some sellers are trying to get away with it by concealing the brand's logo on the products to evade detection. To illustrate ...

Nassau County executive Bruce Blakeman defends the Massapequa High School's logo and mascot as the New York State Board of Regents pushes for rebranding.

The lawsuit alleged that Pfizer’s RSV vaccine, Abrysvo, violated GSK's patent rights in its competing RSV vaccine Arexvy. The companies said they would dismiss the case “with prejudice,” preventing it ...

AI logo makers have come a long way from generic icons and awkward ... Looka’s cheapest $20 plan gives you one low-res PNG file with a colored background. That’s it. No transparent background. No ...

An icon of 3 horizontal dots. An icon of a paper envelope. An icon of a facebook f logo. An icon of a digital camera. An icon of a house. An icon of the Instagram logo. An icon of the LinkedIn logo.

COLUMBUS, Ohio — Ohio Attorney General Dave Yost is pushing to take a leading role in a federal securities lawsuit that accuses pharmaceutical giant GSK, formerly GlaxoSmithKline, of concealing the ...

South Ko­re­an biotech ABL Bio has lined up an­oth­er plat­form li­cense agree­ment with a Eu­ro­pean phar­ma gi­ant in the area of neu­rode­gen­er­a­tive dis­eases.